PRDX6 Overexpression Promotes Proliferation, Invasion, and Migration of A549 Cells in vitro and in vivo
Authors:
Open Access
- 1 February 2021
- journal article
- research article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 13, 1245-1255
Abstract
Purpose: Peroxiredoxin-6 (PRDX6) is frequently found in various cancers. However, its expression and relevance to proliferation, invasion, and migration in human non-small-cell lung cancer (NSCLC) remain unclear. This study investigated the role and novel mechanism of PRDX6 in progression in an NSCLC cell line (A549). Methods: We analyzed the expression of PRDX6 in NSCLC and adjacent normal tissues and explored the proliferation, migration, and invasion of A549 cells using either a PRDX6 plasmid or PRDX6 small interfering RNA (siRNA). We also assessed the effects of PRDX6 on the epithelial–mesenchymal transition (EMT) and β-catenin-mediated transcription of target genes. Results: PRDX6 expression was markedly higher in NSCLC tissues than in adjacent tissues. Proliferation, invasion, and migration of A549 cells were promoted by overexpression of PRDX6 but inhibited by its silencing. PRDX6 overexpression inhibited the protein expression of both phosphorylated β-catenin and E-cadherin, as well as the expression of vimentin, TWIST, and downstream targets of β-catenin including c-MYC, TCF-4, and MMP14. Conversely, PRDX6 silencing markedly decreased the expression of c-MYC, TCF-4, and MMP14, and inhibited EMT in A549 cells. Overexpression of PRDX6 in vivo notably increased the volume and weight of tumors. Conclusion: PRDX6 overexpression promotes the proliferation, invasion, and migration of A549 cells in vitro and in vivo.Keywords
This publication has 17 references indexed in Scilit:
- Identification of PRDX6 as a regulator of ferroptosisActa Pharmacologica Sinica, 2019
- Durvalumab in NSCLC: latest evidence and clinical potentialTherapeutic Advances in Medical Oncology, 2018
- Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLCNature Communications, 2017
- Prdx6 Upregulation by Curcumin Attenuates Ischemic Oxidative Damage via SP1 in Rats after StrokeBioMed Research International, 2017
- Immunotherapy in NSCLC: A Promising and Revolutionary Weapon2017
- Clinicopathologic Features of Advanced Squamous NSCLCJournal of Thoracic Oncology, 2016
- PRDX6 Protects ARPE-19 Cells from Oxidative Damage via PI3K/AKT SignalingCellular Physiology and Biochemistry, 2015
- PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor modelFree Radical Biology and Medicine, 2015
- Wnt Signaling Pathway in Non-Small Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2013
- [Expression and mutation of ?-catenin in non-small cell lung cancer].2004